Key result
The Mycobacterium tuberculosis-specific ELISPOT assay on pericardial effusion mononuclear cells enabled rapid diagnosis of tuberculous pericarditis to guide prompt treatment.
Why the study?
Does the MTB-specific ELISPOT assay on pericardial effusion mononuclear cells enable rapid diagnosis of tuberculous pericarditis?
Does the MTB-specific ELISPOT assay on pericardial effusion mononuclear cells enable rapid diagnosis of tuberculous pericarditis?
The MTB-specific ELISPOT assay on pericardial effusion mononuclear cells may be a useful tool for the rapid diagnosis of tuberculous pericarditis to guide timely treatment.
Answers are grounded in this paper and cite their sources.
May support rapid tuberculous pericarditis diagnosis via pericardial ELISPOT; leaves open need for prospective validation before wider use.
We describe a case in which the rapid diagnosis of tuberculous pericarditis was made using the Mycobacterium tuberculosis (MTB)-specific enzyme-linked immunospot (ELISPOT) assay on pericardial effusion mononuclear cells (PEMCs). The analysis of MTB-specific T-cells in PEMCs by ELISPOT may be useful for rapid decision-making in anti-tuberculous treatment.
No takes yet. Share an insight, caveat, or question.
Kobashi et al. (2010) studied this question. The Mycobacterium tuberculosis-specific ELISPOT assay on pericardial effusion mononuclear cells enabled rapid diagnosis of tuberculous pericarditis to guide prompt treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: